Stocks Health care PMVP
NASDAQ · Health carePMV Pharmaceuticals, Inc. (PMVP)
It posted a net loss of $75.2M. In fiscal 2025 capital spending exceeded operating cash flow by $73.6M. At June 30, 2026 it held $12.5M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
What PMV Pharmaceuticals, Inc. does
PMV Pharmaceuticals, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PMVP.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$77.7M | -$1.48 | -$73.6M |
| 2024 | n/a | -$58.7M | -$1.14 | -$51.9M |
| 2023 | n/a | -$69M | -$1.44 | -$56.6M |
| 2022 | n/a | -$73.3M | -$1.61 | -$71.7M |
| 2021 | n/a | -$57.8M | -$1.28 | -$47.9M |
| 2020 | n/a | -$34.4M | -$2.40 | -$32.9M |
Latest SEC filings
What PMV Pharmaceuticals, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 15, 2026Passive stake (5% or more) SCHEDULE 13G
- September 2, 2026
- September 2, 2026
- August 31, 2026
- August 31, 2026
- August 31, 2026Other event 8-K
- August 14, 2026Quarterly report 10-Q · period to June 30, 2026
- August 14, 2026
- July 28, 2026Passive stake changed SCHEDULE 13G/A
- July 10, 2026Passive stake changed SCHEDULE 13G/A
Questions about PMVP
What does PMV Pharmaceuticals, Inc. do?
PMV Pharmaceuticals, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PMVP.
Is PMV Pharmaceuticals, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $75.2M.
When did PMV Pharmaceuticals, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake (5% or more) from September 15, 2026.
Similar companies
Follow PMVP
Get an email when PMV Pharmaceuticals, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow PMVP: get an email when it filesWhere the numbers come from
Financial figures are the values PMV Pharmaceuticals, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.